Company Filing History:
Years Active: 2011
Title: The Innovations of Serguei Moussatov
Introduction
Serguei Moussatov is a notable inventor based in New York, NY (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of neurodegenerative disorders. His work focuses on innovative methods for delivering therapeutic agents to specific regions of the brain.
Latest Patents
Moussatov holds a patent for the "Use of apoptosis inhibiting compounds in degenerative neurological disorders." This invention provides methods and compositions for localized delivery of a vector comprising a therapeutic agent to regions of the brain affected by neurodegenerative diseases characterized by an excess buildup of intracellular protein aggregates. Specifically, the invention details the use of an adeno-associated virus vector (AAV) that encodes an inhibitor of apoptosis protein (IAP) to target cells in these regions.
Career Highlights
Moussatov has dedicated his career to advancing the understanding and treatment of neurological conditions. His innovative approaches have the potential to significantly improve the quality of life for individuals suffering from these disorders. He is currently associated with Neurologix, Inc., a company focused on developing gene therapies for neurological diseases.
Collaborations
Moussatov collaborates with Michael G Kaplitt, a fellow expert in the field. Their partnership enhances the research and development of effective treatments for neurodegenerative conditions.
Conclusion
Serguei Moussatov's contributions to neuroscience through his innovative patent and collaboration with leading experts highlight the importance of research in developing effective therapies for neurodegenerative disorders. His work continues to pave the way for advancements in this critical area of medicine.